While p53 is dispensable for development, an excess of p53 has dramatic consequences on the embryogenesis and on the cell dierentiation. In an attempt to analyse in vivo the eects of p53 activity, we have generated transgenic mice expressing the wild-type p53 under the control of the metallothionein I promoter. In the three transgenic lines established, exogenous p53 is expressed constitutively in the postmeiotic cells of transgenic males and two lines are subfertile. Transgenic males expressing the upper level of p53 produce few spermatozoa since the majority of developing spermatids undergo apoptosis. In the subfertile males exhibiting an intermediate amount of p53, teratozoospermia is obvious suggesting an altered terminal dierentiation of postmeiotic cells. In contrast lower level of p53 does not lead the third line to sterility. These results suggest that the activity of p53 is dependent in vivo on the amount of p53 present within cells, as it has been already demonstrated in vitro.
Introduction
p53 protein plays an essential role in the response to genotoxic stress. In various normal adult tissues, basal levels of p53 protein are low but DNA damage induces p53 accumulation and activation resulting either in cell cycle arrest or in apoptosis of the damaged cells. This choice may depend on the cell type, probably on the dierentiation state and on the micro-environment of the cell (for review see Levine, 1997) . Nevertheless, the function of p53 protein does not appear to be restricted to extreme conditions of cellular stress and various results suggest a wider role for p53, including that of teratological suppressor throughout development (for review see Hall and Lane, 1997) . While p53 mRNA is widely expressed during murine embryogenesis, p53 appears dispensable for normal mice development. However, some of the p53 null pups die from neural defects; then p53-dependent apoptosis appears to prevent survival of p53+/+ defective embryos. The mdm2 null embryos provide the counterpart of the p53 null model: the upregulated expression of p53 is lethal in mdm27/7 early embryos and this phenotype is rescued in a p53 null genetic background. This con®rmed in vivo that both proteins participate in an autoregulatory loop which is one of the mechanisms regulating p53 turnover (reviewed in Piette et al., 1997) .
In conclusion, a strictly regulated p53 expression is necessary during development and also probably in the adult for homeostasis and/or dierentiation of certain cell lineages.
Tissular homeostasis is essential for organism survival. Numerous tissues are subject to drastic control of their proliferation and cell death, especially apoptosis. Changes in an apoptotic pathway can lead to disease (cancer, auto-immune disorders . . . ; for review see Willie, 1992) . Since p53 protein plays a central role in induction of apoptosis after genotoxic stress, it may also in¯uence apoptosis during normal dierentiation. Some ®ndings point to a potent involvement of p53 in male germ cell dierentiation, a role still poorly understood. During normal rodent meiosis, p53 is transiently expressed in primary spermatocytes and is mainly detected in prophasic spermatocytes SjoÈ blom and LaÈ hdeti, 1996) , following induction of double strand breaks and during generation of synaptonemal complexes. In addition, the in vivo depletion of p53, at least in the 129 strain genetic background, results in a testicular giant-cells syndrome . Nevertheless recent results have shown that p53: (1) is dispensable for meiotic recombination (Gersten and Kemp, 1997) ; (2) and for constitutive apoptosis of spermatogonia and spermatocytes; (3) but is required to induce DNA damage apoptosis of premeiotic cells (Hendry et al., 1996; Odorisio et al., 1998; Hasegawa et al., 1998; Beumer et al., 1998) .
Germ cell tumor is one of the cancers where p53 is stabilized as a wild-type rather than mutant form (Peng et al., 1993; Riou et al., 1995) . In the transformed germ cells, this stabilized wtp53 is activated by DNA damage or by induction of dierentiation, both of which result in cell apoptosis (Chresta et al., 1996; Lutzker and Levine, 1996; Orlovskaya et al., 1997) . This provides a potent explanation of the marked radio-and chemosensitivity of this tumor type (Houldsworth et al., 1998; Zamble et al., 1998; Burger et al., 1998) . Among its reported activities p53 protein acts as a transcriptional activator (reviewed in Agarwal et al., 1998; Levine, 1997) . The involvement of one of its target genes, the cyclin-dependent kinase inhibitor p21waf, in G1 arrest has been demonstrated in vivo (Brugarolas et al., 1995; Deng et al., 1995) . However, the one necessity for p53 dependent transcriptional regulation in apoptosis remains controversial, although several genes involved in apoptosis may be under p53 transcriptional control (i.e. bax and bcl-2 genes, Fas gene) (Miyashita and Reed, 1995; Owen-Schaub et al., 1995) . It is still unclear whether cell-speci®c target genes of p53 exist and which cell factors determine the cell's fate (growth arrest versus apoptosis) upon p53 accumulation and activation. In an attempt to specify in vivo these elements of the p53 pathway in spermatogenesis, we developed a model of transgenic mice overexpressing wtp53. Here we show that the various levels of ectopic wtp53 induced dierent phenotypic alterations in the three transgenic lines generated. Their testicular phenotypes ranged from normality to impaired dierentiation or apoptosis of haploid germ cells.
Results

MTp53 transgenic mice constitutively overexpressed wtp53 in their testes
To counteract a potential lethality due to wtp53 overexpression during embryogenesis and to activate transgene expression in various adult tissues, we used the inducible promoter region of the metallothionein I gene (pMT-I) (Palmiter et al., 1983) . Three founder mice bearing this chimeric MTp53 transgene ( Figure  1a) were generated: females MTp53-94 and 112, and male MTp53-176. Each founder produced heterozygous ospring and analysis of transgene integration revealed various copy numbers: one for line 176, two for line 112 and 15 for line 94 (data not shown). We further analysed the expression of the transgene by Northern blot without any promoter induction. Heterozygous males from each of the MTp53 lines exhibited constitutive expression of the transgene in the testis with dierent mRNA levels ( Figure 1b) : highest for MTp53-94 males and lowest for MTp53-176 males, while slightly increased compared to endogenous p53 mRNA level in this tissue.
The pattern of constitutive expression of the transgene in other tissues varied between transgenic lines (kidney, lung, thymus . . .) and no expression could be detected in liver, large intestine, small intestine, spleen or ovaries (data not shown). These transgenic mice exhibiting heterogeneous constitutive overexpression of wtp53 were viable for 2 years and displayed no obvious diseases under conventional breeding conditions.
Fertility alteration of wtp53 overexpressing males
The MTp53 transgene was constitutively overexpressed in the testes, and while heterozygous MTp53 males exhibited normal copulatory behavior, abnormal fertility was seen in MTp53-94 males, which had the highest p53 expression level. We therefore considered whether the three transgenic lines exhibit an altered reproduction phenotype depending on the levels of exogenous wtp53. Mating pairs were set up so as to investigate the occurrence of these reproductive defects in each of these MTp53 lines. We compared the relative testis weights and the spermatozoa productions of transgenic and control males.
When test-mated 78% of heterozygous MTp53-94 males were infertile whatever the female genotypes and the ages of the males (data not shown). In addition, matings between heterozygous MTp53-94 mice were either unproductive or never generated homozygous transgenic mice (data not shown). The heterozygous MTp53-94 males exhibited marked testicular atrophy ( Figure 2a ): on average a halving of the relative testis weights, which signi®cantly diered from normal weights from the age of 7 weeks onwards. This testicular atrophy was associated with a drastic reduction in the mature spermatozoa population in the cauda epididymis (Figure 2b ) to an average of less than 10% of the normal production from the age of 2 months. It should be noted that the spermatozoa population of the rare fertile MTp53-94 males was 20 to 30% that of the controls (data not shown).
About 60% of the heterozygous MTp53-112 males, exhibiting a moderate level of transgene expression, were sterile irrespective of their age and of the female genotypes (data not shown). Their relative testis weights and spermatozoa production were not signi®cantly altered compared to controls ( Figure  2a,b) . However, the rare homozygous MTp53-112 males were infertile when mated with normal females.
Heterozygous transgenic MTp53-176 males, which exhibited the lowest transgene expression level in the testes, were as fertile as control males (data not shown). On the other hand, heterozygous MTp53 females of the three lines were fertile as their normal counterparts and transmitting the transgene in a mendelian way (data not shown).
In conclusion, testicular wtp53 overexpression in heterozygous MTp53-94 and 112 males resulted in ; introns and exons are not represented) and the white box is the SV40 polyadenylation signal. (b) The MTp53 transgene was constitutively expressed at dierent levels in the testis of 2-month-old transgenic mice. Five mg of total testis RNA from the transgenic males from the three lines were hybridized with a partial p53 cDNA probe; 1: control, 2: MTp53-94; 3: MTp53-176 and 4: MTp53-112. Equal amounts of total RNA were present in each slot as shown by ethidium bromide staining subfertility, while spermatozoa production diered between the two transgenic lines. These sterility studies only gave semi-quantitative results: the spermatozoa population in rodents must be reduced to less than 10% to induce infertility (Russell et al., 1990) . In addition, these analyses suggested that the phenotype of infertility is related to the level of MTp53 transgene expression, since the MTp53-176 males were unaffected. Our subsequent studies therefore focused on heterozygous males from lines MTp53-94 and 112, displaying various levels of transgene expression in their testis and dierent phenotypes.
The histology of seminiferous tubules con®rmed the testicular atrophy of MTp53-94 males
The testis is organized in seminiferous tubules in which cycles of germ cell dierentiation occur throughout life (reviewed in Russell et al., 1990) . The stem cells, spermatogonia, undergo either self-renewal or differentiate into primary spermatocytes which one enter meiosis producing haploid spermatids (spermatogenesis), which terminally dierentiate into spermatozoa (spermiogenesis).
Histological examination of the seminiferous tubules of MTp53-94 males con®rmed the previously observed depletion in mature spermatozoa: numerous seminiferous tubules contained no elongating spermatid and lacked mature germ cells (Figure 3b ) while numerous elongating spermatids were observed in control sections ( Figure 3a) . However, the earlier stages of differentiation from spermatogonia to round spermatids were seen in all transgenic tubules. The histology of the seminiferous tubules of MTp53-112 males was normal in line with previous results (data not shown).
In conclusion, this clearly impaired spermiogenesis readily explains the sterility of MTp53-94 males, whose poor spermatozoa production resulted from a blockage of spermatid maturation.
p53 accumulated in germ cells undergoing terminal dierentiation
To determine the developmental onset of exogenous wtp53 expression in transgenic testis, we performed immunohistological analysis using a monoclonal antibody against p53 (PAb240). During postnatal development of mouse testis, cells advance synchronously toward meiosis and the ®rst spermatids are observed at 22 ± 24 days. Consequently, by assaying the testis at dierent times during this ®rst spermatogenic cycle, the cell type in which a gene product is ®rst expressed can be identi®ed. In 4-week-old MTp53-94 seminiferous tubules (Figure 3d ), the anti-p53 labeling was restricted to the nuclei of central cells, demonstrating an exogenous wtp53 expression in round spermatids. Afterwards, in the adult testis, the various cell types appear concomitantly, in waves, on average every 35 days. As shown on Figure 3e , the ectopic p53 was also detected within postmeiotic cells of adult MTp53-94 males: only cells surrounding the lumen were labeled suggesting that haploid cells expressed exogenous p53 all along their terminal dierentiation. A similar pattern of expression was observed for the two other transgenic lines MTp53-112 ( Figure 3f ) and 176 (data not shown) expressing lower levels of transgene. In all three transgenic lines wtp53 was detected neither within spermatogonia nor spermatocytes and no evidence of expression was obtained in somatic cells. In addition wtp53 was not detected in spermatozoa, as Figure 3f clearly shows, despite the transgene presence detected by PCR in spermatozoa from the cauda epididymis (data not shown).
The exogenous wtp53 accumulated from the ®rst postnatal wave of spermatogenesis onwards and was maintained in further cycles in the MTp53 adult testis. The ectopic presence of wtp53 within spermatids might account for the impaired spermiogenesis and subfertility of MTp53-94 and 112 males, respectively.
Accumulation of wtp53 during spermiogenesis resulted in apoptosis
The weight decrease of testes concomitant with the altered spermatozoa production suggested that wtp53 overexpression in the spermatids of MTp53-94 males might induce apoptosis but analysis of the histological sections did not reveal any apoptotic bodies. They might be released into the lumen and/or phagocytosed by Sertoli cells very rapidly (Blanco- Rodriguez and Martinez-Garcia, 1996) . Several morphological modi®cations, such as chromatin and cytoplasm condensations and membrane alterations which precede the cell fragmentation, can be studied using electron microscopy. Altered spermiogenesis was seen in numerous (6280) tubules of the MTp53-94 mouse testis generally depleted in spermatozoa. Disintegration of the seminiferous epithelium, with partial disappearance of intercellular bridges normally characterizing this dierentiation process, led to the release of newly formed spermatids into the lumen of the tubules (Figure 4a,b) . In these abortive spermatids, the development of the acrosome from the Golgi vesicles occurred as in controls (Figure 4c) , and the mitochondria were normal. However, from step IX their nuclei were frequently abnormally shaped due to membrane blebbing, and contained condensed chromatin and/or dense granules of various sizes ( Figure  4d ). The shapes of spermatogonial cells in interphase or in mitosis, and of spermatocytes were apparently normal.
Spermatids displayed a classical apoptotic morphology, which was strongly substantiated by the in situ DNA fragmentation analysis (TUNEL: TdT-mediated dUTP nick end labeling). In normal testis apoptosis mainly occurred in spermatogonia and spermatocytes and the resulting labeled cells were located near the basement membrane (Figure 5d ). Moreover some pachytene spermatocytes may be labeled by the in situ method, probably due to the process of genetic recombination (Blanco- Rodriguez and Martinez-Garcia, 1996) . Besides this normal apoptotic process, in adult MTp53-94 testis several seminiferous tubules contained labeled cells around the lumen (Figure 5a ,b, and c) which suggested that postmeiotic cells were undergoing apoptosis. This adluminal labeling hallmark of an apoptotic process in MTp53-94 testis was absent from sections of MTp53-112 seminiferous tubules (data not shown). To estimate the extent of the p53 induced apoptosis, we performed a semiquanti®cation of the TUNEL-labeled cells on testis sections from two fertile males of the MTp53-94 line. This estimation took into account all the labeled cells, including those involved in meiotic recombination, but excluded`already fragmented cells' due to the lack of apoptotic bodies. As shown in Table 1 , apoptosis in the testis, even of fertile MTp53-94 males, was greater than in controls, whatever their age.
Spermatozoa defects induced by accumulation of lower p53 levels
More than half of the MTp53-112 males were sterile without any signi®cant depletion in spermatozoa production despite the accumulation of wtp53 in spermatids. There are various possible ways of explaining this subfertility: decreased mobility of spermatozoa, shape defects or an inability to fertilize. We analysed the mobility and shape of mature spermatozoa from the cauda epididymis, and estimated the percentage of abnormal gametes. The MTp53-112 males produced spermatozoa as mobile as control (over 50%), but teratozoospermy was increased. While normal seminal¯uid contained 14% (+2.3%) of abnormal gametes, mainly spermatozoa exhibiting an altered hook or¯agellum, the seminal uid from MTp53-112 males contained 61% (+11%) of abnormal cells in roughly equal proportions of isolated heads and spermatozoa with an altered hook or¯agellum. These data suggested that the subfertility of MTp53-112 males resulted from the production of an increased number of defective mature spermatozoa.
Discussion
We have described an in vivo model of testicular wtp53 overexpression resulting in spermiogenesis defects and consequent infertility. The high level of ectopic wtp53 within spermatids led to apoptosis as in the testis of MTp53-94 males, while lower levels resulted in terminal dierentiation impairment and production of abnormal spermatozoa as in MTp53-112 testis. Therefore, this model suggests that p53 activity observed in vivo is a function of p53 levels within cells.
p53 accumulated in the spermatids of transgenic males from the three lines
The MTp53 expression in testis, whatever the transgenic line, appeared to be dependent on copy number and especially on cell-speci®city. The endogenous MTI gene is expressed in pachytene spermatocytes and round spermatids, but is silent in spermatozoa (De et al., 1991) . In the three MTp53 lines, exogenous wtp53 clearly accumulated within spermatid nuclei and was lacking in spermatozoa. However, we cannot rule out p53 overexpression in several pachytene cells overlapping endogenous p53 expression during meiosis SjoÈ blom and LaÈ hdeti, 1996) . Immunohistological analysis performed on isolated transgenic germ cells was inconclusive. Consequently, we consider that the impairment of fertility in heterozygous transgenic 94 and 112 males only resulted from ectopic wtp53 expression during terminal dierentiation of spermatids, noncyling haploid cells.
Organization in syncytial form enhances the consequences of wtp53 overexpression
Numerous heterozygous transgenic males in both lines 94 and 112 were sterile, although their haploid spermatids were genetically distinct (transgenic versus normal). In seminiferous tubules, germ cells are linked by intercellular bridges as a syncytium and the progeny of each committed stem cell develops as a clone from premeiotic divisions to postmeiotic maturation. The transfer of transgene mRNA and protein across the bridges could be expected to lead to complete sterility of heterozygous males, even if the expression is restricted to the haploid spermatids (Braun et al., 1989) . Therefore, wtp53 expression within syncytia was expected to be homogeneous among the spermatid population despite the fact that spermatids were genetically dierent.
Nevertheless, transgene penetrance was not ecient enough to result in 100% sterility of heterozygous transgenic males in both lines: (1) Since the epithelium is greatly disorganized, at in least in MTp53-94 testis, the transfer eciency of mRNA and proteins could be reduced; (2) MTI promoter activity could be heterogeneous among cells and/or syncytia. In this way, the MTI promoter directs both TATA-dependent and TATA-independent modes of transcription, the latter predominating in germ cells (Garrity and Wold, 1990) . One can consider that these two modes of transcription might interfere and/or that epigenetic events (methylation, chromatin remodeling . . .) might modulate their uses, in both cases leading to reduced p53 levels within cells. This phenomenon is supported by the lack of transgene expression in 8% of the mature spermatozoa of transgenic males homozygous for the protamine 1 regulatory sequences fused to the growth hormone gene (Braun et al., 1989) .
The extent and nature of cellular damage are directly related to p53 levels As previously described, although the ectopic p53 is expressed in the spermatids of the males from the three transgenic lines, the consequences for germ cell production dier greatly: null for MTp53-176 males and dramatic for MTp53-94 and 112 males. As it is unlikely to result from an eect of the transgene sites of integration (i.e. insertional mutagenesis), this underscores the importance of the threshold levels of p53 within a cell as regards to p53 functions. Modulation of p53 activities (i.e. apoptosis versus G1 arrest) appears to be directly dependent on p53 level, as well as cell type. The three MTp53 transgenic lines created displayed distinct reproductive phenotypes, suggesting that p53 threshold is necessary in vivo to induce spermiogenesis alterations. Low amounts of p53 did not obviously impair terminal dierentiation, as shown by fertile transgenic 176 males. In contrast, higher levels of p53 within MTp53-94 and 112 spermatids led to subfertility by two dierent mechanisms depending on p53 cellular amounts: dierentiation impairment and apoptosis induction. Such p53 cell speci®c dose-dependent responses have also been observed in the developing kidney (altered dierentiation) and in the lens (apoptosis induction) of other wtp53 transgenic models (Nakamura et al., 1995; Godley et al., 1996) . They might be related to modulation of p53 functions: by expressing p53 in p53 null cell lines, lower levels of p53 result in growth arrest while higher levels induce apoptosis (Chen et al., 1996; Adachi et al., 1998) . Furthermore, growth arrest is directly dependent on p53 transcription activity, which is not sucient to induce apoptosis.
p53 protein can alter terminal dierentiation of MTp53-112 germ cells
Moderate level of p53 within MTp53-112 spermatids may mainly act as a transcription factor, in particular by sequence-speci®c transactivation (SST) of p53-responsive genes. Since numerous genes are transcribed during meiosis and in the early stages of spermatid dierentiation, the ectopic p53 may modulate the expression of several genes involved in spermiogenesis. As this postmeiotic dierentiation is subject to drastic transcriptional and translational controls, wtp53 overexpression could easily upset the balance of this process. The main potent candidate is the p53-regulated p21 gene, whose expression has been detected in spermatocytes and in early spermatids, suggesting involvement of p21waf1 not only during meiosis but also during terminal dierentiation (Beumer et al., 1997; West and LaÈ hdetie, 1997) . It should be noticed that several Cdk family genes coding for potent p21waf binding kinases are also expressed in spermatids (Rhee and Wolgemuth, 1995; Gromoll et al., 1997) . Consequently, an imbalance in the p21waf-CDK interaction might impair the maturation of spermatids. On the other hand, diverse genetic alterations can result in severe spermiogenesis defects (for review see Sassone-Corsi, 1997) : the inactivation of the CREM gene disrupting the cAMP pathway blocks spermiogenesis entry, dysregulating postmeiotic chromatin remodeling clearly leads to altered spermatids and alteration of the interactions between Sertoli and germ cells may also markedly alter spermiogenesis. Therefore, several of the putative p53 target genes might be involved in one of these pathways critical for spermatid dierentiation.
Above a threshold, p53 induces apoptosis of spermatids
The mechanisms underlying p53-dependent apoptosis remain unclear, but it is already established that a non transcriptional component is involved in certain cell types (Caelles et al., 1994) . The polyproline domain of the p53 N-terminal region is supposed to mediate this role (Haupt et al., 1995; Chen et al., 1996; Sakamuro et al., 1997; Zhu et al., 1998) . This proline-rich motif could participate in: (1) the protein ± protein interactions linking p53 to SH3 proteins, and potentially signal transduction pathways (Levine, 1997) ; (2) the transcriptional repression by p53, a process which is not yet well understood (Venot et al., 1998) . However, this polyproline domain may also participate in p53 SST, probably in the binding anity discrepancy between sites (Venot et al., 1998; Zhu et al., 1998) . The link between apoptosis and SST has already been observed in several tissues in vivo (MacCallum et al., 1996; Komarova et al., 1997; Gottlieb et al., 1997) .
Therefore higher levels of p53 in MTp53-94 testis may also trigger spermatid apoptosis through SST. Among the p53 target genes involved in apoptosis (reviewed in: Levine, 1997; Agarwal et al., 1998) , the bax gene appears as a good candidate: (1) it is a p53-upregulated gene (Miyashita and Reed, 1995) ; (2) Bax, an apoptosis activator, is necessary for spermatogenesis since bax null mice are sterile due to a cellular block at a premeiotic step (Knudson et al., 1995) . The expression and activity of Bax appear restricted to the ®rst postnatal cycle of germ cell dierentiation, characterized by an apoptotic wave probably necessary to ensure the balance between Sertoli and germ cells; then Bax is neither detected within spermatids nor in the adult testis (Rodriguez et al., 1997) . Therefore bax gene SST by p53 could contribute to MTp53-94 spermatid apoptosis. In the adult testis, Bclw, an apoptosis inducer member of Bcl2 family has recently been implicated in apoptosis of germ cells (Ross et al., 1998; Print et al., 1998) . However, a potent SST link between p53 and the bclw gene has not been reported yet.
The expression of Fas ligand by Sertoli cells could confer on testis its immune privilege status and may be a potent way to delete defective germ cells (Bellgrau et al., 1995; Lee et al., 1997) . Since the Fas receptor gene can be transactivated in response to p53 in certain circumstances (Owen-Schaub et al., 1995; Reinke and Lozano, 1997) , the fas-bearing spermatids might be eliminated in the testis of MTp53-94 males.
In parallel to these two apoptotic pathways described in testis, the production of reactive oxygen species (ROS) via p53 SST clearly participates in apoptosis of several cell types (Polyak et al., 1997; Komarova et al., 1998) . Since testicular oxygenation is naturally reduced (Zheng and Olive, 1997) , germ cells are especially sensitive to hypoxia and p53-induced generation of ROS might also be involved in the deletion of transgenic spermatids. Consequently, at least three potent pathways of apoptosis directly depending on p53 SST could lead to the phenomenon observed in MTp53-94 testis.
This model is a potent tool in analysis of the mechanisms of p53 activation which appear to be related to cellular dierentiation status especially in germ cells (Lutzker and Levine, 1996) . Understanding of the apoptotic pathway(s) involved in the transgenic spermatid deletion might enable characterization of the factors responsible for the impressive curability of the majority of testicular tumor cells accumulating wtp53. This could lead to alternative approach of therapies of resistant testicular tumors.
Materials and methods
Construction of the MTp53 transgene
The murine wtp53 genomic sequences were fused to the 1.8 kb 5'¯anking region of the murine metallothionein-I gene (pMT-I) in three steps. The p53 cDNA was isolated from pSp6p53 ala by EcoRI-SalI digestion (this latter site was ®lled with Kleenow DNA polymerase I) and inserted downstream of the EcoRI ± BqIII pMT-I, in the EcoRI ± SmaI digestion of pUCMTI-2 plasmid (generously provided by Dr Kress). This plasmid was cut by AatII and SalI to generate a 2185 bp fragment, and by AatII and XhoI to yield a 2502 bp fragment including the p53 cDNA (sequences 1 to 159) downstream of pMT-I. Both fragments were ligated with a XhoI ± SalI digest of LTRp53cG ala plasmid containing the genomic sequences of wtp53 and the polyadenylation site of SV40 (generously provided by Dr Oren) (Eliyahu et al., 1985) . The resulting plasmid was designated MTmp53cG ala .
Generation and screening of MTp53 transgenic mice
The 6.4 kb chimeric gene was excised from MTmp53cG.ala sequences by digestion with SalI which cuts 12 bp upstream from the pMT-I promoter and 276 bp downstream from the SV40 polyadenylation signal. Each founder animal was mated to a C57BL/6 mouse to establish distinct heterozygous transgenic lines with a C57BL/6 genetic background. Normal C57BL/6 mice were used as controls. Transgenic mice were detected by Southern blot analysis of tail DNA digested with BamHI, probed with the exons 2 ± 6 of murine p53 cDNA (a 605 bp fragment from LR10 plasmid kindly provided by Dr Donehower). The copy number of the transgene was determined on Southern blots using a Biorad phosphorImager; the absolute gene copy number was estimated by hybridization using the endogenous p53 band as a reference (two alleles of p53 per genome).
All animal procedures reported in this paper were carried out in accordance with French Government regulations.
RNA preparation and Northern blot analysis
For Northern blot analysis, frozen tissue samples were ground to a powder under liquid nitrogen and then homogenized in 4 M guanidium thiocyanate. RNAs were pelleted through a 5.7 M CsCl cushion and puri®ed as described by Chirgwin et al. (1979) . RNA samples were electrophoresed in formaldehyde-containing agarose gel and then transferred to a Hybond-N membrane (Amersham). The membrane was hybridized in a 50% formamide-containing medium with the probe of interest.
Fertility and fecundity of mice
Fertility was determined for heterozygous males up to 7-weeks-old in each transgenic line (24 MTp53-94 males and 28 MTp53-112 males). Normal or transgenic females were left with transgenic males for 15 days or more and checked for pregnancy. At the end of this mating regimen, males were harvested for 3 days before analysis. Transgenic females were also test-mated according to the same protocol.
Tissue weight and epididymis cell count determination
The mice were killed by avertin injection. The right testis was weighed and the respective cauda epididymis was dilacerated in phosphate-buered saline. Un®xed spermatozoa were incubated at 378C for 20 min before counting with a Mallassez hematocytometer. Cells with a head and tail were regarded as sperm cells irrespective of morphological abnormalities using phase contrast microscopy. A minimum of ®ve males per age for both transgenic and control mice were used. Two-way ANOVA with repeated measures (genotype6weeks) was used to analyse the data.
Histological procedure
The testes were stripped of the tunica albuginea and the equally divided samples were processed for either paran or Epon-Araldite embedding. Morphological analyses were performed on 7 mm paran sections of testis ®xed in 4% paraformaldehyde in phosphate-buered saline and stained with hemalun and picro-indigo carmine. Electron microscopy specimens were ®xed for 1 h in 2% glutaraldehyde and 0.1% paraformaldehyde in 0.075 M phosphate buer. Just before use, 0.5% potassium ferricyanide was added to the ®xative. After being washed three times in the buer, samples were osmicated for 50 min in 1% aqueous osmium tetroxide solution, dehydrated in an ethanol series and embedded. Ultrathin sections were stained with uranyl acetate and lead nitrate, and observed with a Phillips 201 microscope.
Immunohistochemistry
After paran removal, 4% paraformaldehyde ®xed testis sections were boiled twice for 5 min in 10 mM sodium citrate buer pH 6 in a micro-wave oven (750 W). After cooling for 20 min at room temperature, sections were labeled with the PAb 240 anti-p53 by an indirect immunoperoxidase technique using an ABC Vectastain kit (Vector Laboratories) and diaminobenzidine-H 2 O 2 (Sigma) and counterstained with hematoxylin.
In situ detection of apoptotic bodies and quanti®cation
The TUNEL method was applied to 7 mm testis sections ®xed in 4% paraformaldehyde after paran removal (Gavrieli et al., 1992) . After 10 min incubation in 2% levamisol-PBS to block endogenous alkaline phosphatases, the labeled DNA fragments were revealed by the streptavidin-alkaline phosphatase technique using Vector Red (Vector Laboratories). Nuclei were counterstained with Dapi. Pictures were picked up using a Nikon microphot-FXA microscope coupled to a Princeton Instruments camera (Model 12 bits RTE) with an IPLab Spectrum 3.1.1 application (Signal Analytics). For semi-quantitative analysis, two transgenic males of dierent ages were used with their normal counterpart. The percentages of labeled nuclei were determined from random pictures of ®ve dierent sections (3000 counted nuclei) using the Optilab Pro 2.6.2 application (Grabtek).
